Characterisation of the nociceptive phenotype of suppressible galanin overexpressing transgenic mice

Research output: Contribution to journalArticle (Academic Journal)

9 Citations (Scopus)


The neuropeptide galanin is widely expressed in both the central and peripheral nervous systems and is involved in many diverse biological functions. There is a substantial data set that demonstrates galanin is upregulated after injury in the DRG, spinal cord and in many brain regions where it plays a predominantly antinociceptive role in addition to being neuroprotective and pro-regenerative. To further characterise the role of galanin following nerve injury, a novel transgenic line was created using the binary transgenic tet-off system, to overexpress galanin in galaninergic tissue in a suppressible manner. The double transgenic mice express significantly more galanin in the DRG one week after sciatic nerve section (axotomy) compared to WT mice and this overexpression is suppressible upon administration of doxycycline. Phenotypic analysis revealed markedly attenuated allodynia when galanin is overexpressed and an increase in allodynia following galanin suppression. This novel transgenic line demonstrates that whether galanin expression is increased at the time of nerve injury or only after allodynia is established, theneuropeptide is able to reduce neuropathic pain behaviour. These new findings imply that administration of agalanin agonist to patients with established allodynia would be an effective treatment for neuropathic pain
Original languageEnglish
JournalMolecular Pain
Publication statusPublished - Oct 2010

Fingerprint Dive into the research topics of 'Characterisation of the nociceptive phenotype of suppressible galanin overexpressing transgenic mice'. Together they form a unique fingerprint.

  • Projects

    Cite this